Malignant Oral and Maxillofacial Tumors A Retrospective Study at Al-Amal National Hospital, Medical City, Baghdad (2024–2025)"
Fuente:
Zenodo
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Recurso digital |
| Sprache: | Englisch |
| Veröffentlicht: |
Zenodo
2026
|
| Schlagworte: | |
| Online-Zugang: | |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| _version_ | 1866901352582479872 |
|---|---|
| author | Dr Tiyba Sattar Supervisor1:Dr lamiaa alnakib ,Supervisor2:Dr Sabar Shukri |
| author_facet | Dr Tiyba Sattar Supervisor1:Dr lamiaa alnakib ,Supervisor2:Dr Sabar Shukri |
| contents | <p>Background: Oral and maxillofacial malignancies constitute a significant global health burden due to their aggressive biological behavior and impact on morbidity and mortality.<br>Aim: To evaluate the frequency, distribution, and clinicodemographic characteristics of oral and maxillofacial malignant tumors diagnosed at Al- Amal National Hospital during 2024–2025.<br>Materials and Methods: A retrospective descriptive study was conducted using data obtained from the Cancer Registration Unit. A total of 326 confirmed malignant cases were included. Variables analyzed included age, gender, anatomical site (diagnostic code), and treatment modalities. Descriptive statistics were applied using frequencies and percentages. Results: Oral and maxillofacial malignancies represented 3.2% of total hospital attendees. A male predominance was observed (58.6%). The majority of cases occurred in patients aged 41–60 years (36.5%) and 61–89 years (35.6%). Lymphoma (35.9%) was the most frequent malignancy, followed by nasopharyngeal tumors (21.2%) and lip malignancies (11.7%). Chemotherapy was the most commonly administered treatment modality (80.4%).<br>Conclusion: The study demonstrates a clear age-related trend, male predominance, and clustering of malignancies within specific anatomical sites. These findings provide important institutional baseline data for future epidemiological research in Iraq.</p> |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_20028143 |
| institution | Zenodo |
| language | eng |
| publishDate | 2026 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | Malignant Oral and Maxillofacial Tumors A Retrospective Study at Al-Amal National Hospital, Medical City, Baghdad (2024–2025)" Dr Tiyba Sattar Supervisor1:Dr lamiaa alnakib ,Supervisor2:Dr Sabar Shukri Malignant <p>Background: Oral and maxillofacial malignancies constitute a significant global health burden due to their aggressive biological behavior and impact on morbidity and mortality.<br>Aim: To evaluate the frequency, distribution, and clinicodemographic characteristics of oral and maxillofacial malignant tumors diagnosed at Al- Amal National Hospital during 2024–2025.<br>Materials and Methods: A retrospective descriptive study was conducted using data obtained from the Cancer Registration Unit. A total of 326 confirmed malignant cases were included. Variables analyzed included age, gender, anatomical site (diagnostic code), and treatment modalities. Descriptive statistics were applied using frequencies and percentages. Results: Oral and maxillofacial malignancies represented 3.2% of total hospital attendees. A male predominance was observed (58.6%). The majority of cases occurred in patients aged 41–60 years (36.5%) and 61–89 years (35.6%). Lymphoma (35.9%) was the most frequent malignancy, followed by nasopharyngeal tumors (21.2%) and lip malignancies (11.7%). Chemotherapy was the most commonly administered treatment modality (80.4%).<br>Conclusion: The study demonstrates a clear age-related trend, male predominance, and clustering of malignancies within specific anatomical sites. These findings provide important institutional baseline data for future epidemiological research in Iraq.</p> |
| title | Malignant Oral and Maxillofacial Tumors A Retrospective Study at Al-Amal National Hospital, Medical City, Baghdad (2024–2025)" |
| topic | Malignant |
| url | https://doi.org/10.5281/zenodo.20028143 |